Leveraging Immunopeptidomics To Study and Combat Infectious Disease
T cells must recognize pathogen-derived peptides bound to major histocompatibility complexes (MHCs) in order to initiate a cell-mediated immune response against an infection, or to support the development of high-affinity antibody responses. Identifying antigens presented on MHCs by infected cells...
Enregistré dans:
Auteurs principaux: | Owen K. Leddy, Forest M. White, Bryan D. Bryson |
---|---|
Format: | article |
Langue: | EN |
Publié: |
American Society for Microbiology
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/933d0ab64c25497f97fe5f6157b51f9f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Biocontainment in Gain-of-Function Infectious Disease Research
par: W. Ian Lipkin
Publié: (2012) -
Preserve a Voucher Specimen! The Critical Need for Integrating Natural History Collections in Infectious Disease Studies
par: Cody W. Thompson, et autres
Publié: (2021) -
The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19
par: Arturo Casadevall, et autres
Publié: (2021) -
Emerging Infectious Diseases in 2012: 20 Years after the Institute of Medicine Report
par: David M. Morens, et autres
Publié: (2012) -
Host-Microbe Metagenomics: a Lens To Refocus Our Perspective on Infectious and Inflammatory Diseases
par: Katrina L. Kalantar, et autres
Publié: (2021)